Milani Michela, Starinieri Francesco, Beretta Stefano, Monti Marco, Canepari Cesare, Marabotti Francesca, Zambrano Samuel, Mazza Davide, Fabiano Anna, Simoni Chiara, Cammarota Eugenia, Volpin Monica, Bortolussi Giulia, Russo Fabio, Biffi Mauro, Genua Marco, Degl'Innocenti Sara, Sanvito Francesca, Ostuni Renato, Muro Andrés F, Montini Eugenio, Moalli Federica, Iannacone Matteo, Merelli Ivan, Cantore Alessio
San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita Salute San Raffaele University, Milan, Italy.
J Hepatol. 2025 Jul 3. doi: 10.1016/j.jhep.2025.06.018.
Hepatocytes are the primary cells of the liver, essential for metabolism and important targets for in vivo gene therapy, which has the potential to treat monogenic diseases caused by defects in their functions. Integrating the transgene into the target cell's genome is crucial for long-term expression following a single dose administered early in life, achievable through integrating vectors or genome editing. To ensure the persistence of the genetic modification throughout liver growth and turnover, it is also necessary to target the cells involved in these processes. Although previous research has focused on liver homeostasis and regeneration, the growth and maturation of hepatocytes remain not fully understood. Here, we explore the evolution of hepatocyte heterogeneity during liver growth and evaluate its implications for in vivo gene engineering.
We performed clonal tracing, single-cell and spatial transcriptomics on mouse livers of various ages. We evaluated the efficiency, stability, and lobule distribution of lentiviral gene transfer and targeted transgene integration.
We found that a subset of clonogenic hepatocytes (15-20%) in the newborn liver generates >90% of the adult tissue and co-localizes with hematopoietic islands within a spatial niche. Preferential gene editing of these clonogenic hepatocytes resulted in an increased proportion of the gene-engineered liver area, supporting their role in liver growth. Age-dependent hepatocellular heterogeneity affected the efficiency of lentiviral gene delivery in vivo and its distribution throughout the hepatic lobule. The gradual establishment of metabolic zonation after weaning and elevated proteasome activity in the peri-central area in adults influenced the observed age-related outcomes.
These insights into spatiotemporal hepatocyte dynamics enhance our understanding of liver biology and have important implications for therapeutic strategies.
We provide new insights into the spatiotemporal dynamics of the mouse liver during postnatal growth, highlighting both proliferative and transcriptomic heterogeneity among hepatocytes and their impact on the efficiency and distribution of in vivo lentiviral gene delivery and targeted gene editing. Understanding and manipulating the biological processes behind this heterogeneity can enhance gene transfer outcomes. We report that not all hepatocytes contribute equally to liver growth, indicating that effectively targeting clonogenic hepatocytes in the newborn liver is crucial for the long-term maintenance of therapeutic genetic modifications. Furthermore, this phenomenon can be leveraged to expand the pool of genetically corrected cells, as illustrated here by a targeted gene editing strategy. Finally, we reveal the existence of a tissue niche that supports the proliferation of both clonogenic hepatocytes and hematopoietic progenitors in neonatal livers. Gaining a deeper understanding of this niche and its signals could be beneficial for regenerative purposes.
肝细胞是肝脏的主要细胞,对新陈代谢至关重要,也是体内基因治疗的重要靶点,体内基因治疗有潜力治疗因肝细胞功能缺陷引起的单基因疾病。将转基因整合到靶细胞基因组中对于在生命早期单次给药后的长期表达至关重要,这可通过整合载体或基因组编辑来实现。为确保基因修饰在肝脏生长和更新过程中持续存在,还需要靶向参与这些过程的细胞。尽管先前的研究集中在肝脏稳态和再生方面,但肝细胞的生长和成熟仍未完全了解。在此,我们探索肝脏生长过程中肝细胞异质性的演变,并评估其对体内基因工程的影响。
我们对不同年龄小鼠的肝脏进行了克隆追踪、单细胞和空间转录组学研究。我们评估了慢病毒基因转移和靶向转基因整合的效率、稳定性及小叶分布。
我们发现新生肝脏中一部分克隆源性肝细胞(15%-20%)产生了>90%的成年组织,并与空间生态位内的造血岛共定位。对这些克隆源性肝细胞进行优先基因编辑导致基因工程肝脏区域的比例增加,支持了它们在肝脏生长中的作用。年龄依赖性肝细胞异质性影响了体内慢病毒基因递送的效率及其在肝小叶中的分布。断奶后代谢分区的逐渐建立以及成年小鼠中央周围区域蛋白酶体活性的升高影响了观察到的与年龄相关的结果。
这些对肝细胞时空动态的见解加深了我们对肝脏生物学的理解,并对治疗策略具有重要意义。
我们提供了关于小鼠出生后生长期间肝脏时空动态的新见解,突出了肝细胞之间的增殖和转录组异质性及其对体内慢病毒基因递送效率和分布以及靶向基因编辑的影响。理解和操纵这种异质性背后的生物学过程可以提高基因转移效果。我们报告并非所有肝细胞对肝脏生长的贡献都相同,这表明在新生肝脏中有效靶向克隆源性肝细胞对于治疗性基因修饰的长期维持至关重要。此外,这种现象可被利用来扩大基因校正细胞库,如此处通过靶向基因编辑策略所示。最后,我们揭示了在新生肝脏中存在一个支持克隆源性肝细胞和造血祖细胞增殖的组织生态位。更深入地了解这个生态位及其信号可能对再生目的有益。